Lithuanian ultrafast laser manufacturer contributing specialized photonics hardware and nonlinear optics expertise to European microscopy and biophotonics research consortia.
Light Conversion is a Lithuanian photonics company that manufactures ultrafast laser systems and optical parametric amplifiers. In the H2020 context, they contribute specialized laser and light source technology to research consortia working on advanced microscopy, spectroscopy, and optoelectronic materials. Their role is typically as an industry partner providing the ultrafast laser hardware and nonlinear optical expertise that enables scientific breakthroughs in biophotonics, materials characterization, and clinical imaging. They bridge the gap between laser engineering and applied photonics research across life sciences and materials science.
Core technology contributor across all three projects — MUSIQ (ultrafast spectroscopy), FAIR CHARM (coherent harmonic microscopy), and TADFlife (optical characterization of OLED materials).
Central to both MUSIQ (multiphoton microscopy, vibrational microscopy) and FAIR CHARM (multiphoton microscopy, infrared harmonic microscopy).
MUSIQ addressed biophotonics applications; FAIR CHARM explicitly targets clinical translation and cytometry using short-wave infrared imaging.
TADFlife project focused on thermally activated delayed fluorescence and phosphorescence in organic light-emitting materials.
Light Conversion's H2020 journey shows a clear shift from materials science toward biomedical photonics. Their earliest involvement (TADFlife, 2018) centered on organic light-emitting materials — characterizing fluorescence and phosphorescence in OLED compounds. By 2019-2022, their focus pivoted sharply toward advanced microscopy for life sciences, with MUSIQ covering multiphoton and vibrational microscopy and FAIR CHARM pushing into clinical translation with infrared imaging and cytometry.
Light Conversion is moving decisively toward clinical and biomedical applications of their ultrafast laser technology, making them a strong partner for future projects at the photonics-medicine interface.
Light Conversion operates exclusively as a participant or third-party contributor — they have never coordinated an H2020 project. With 44 unique partners across 16 countries from just 3 projects, they plug into large, diverse research consortia (typical of MSCA training networks and RIA projects). This profile suggests a specialist equipment provider that researchers actively seek out for their laser technology rather than an organization that initiates consortium-building.
Despite only 3 projects, Light Conversion has built a wide network of 44 partners spanning 16 countries — a direct result of participating in large MSCA training networks. Their reach is pan-European with no obvious geographic clustering beyond a natural connection to the Baltic and Nordic photonics communities.
Light Conversion is one of very few commercial ultrafast laser manufacturers participating directly in EU research consortia. While most laser companies sell equipment at arm's length, LC embeds within projects as a technology partner, giving consortia direct access to laser engineering expertise alongside hardware. For consortium builders, this means getting both the instruments and the know-how to push them beyond standard specifications — particularly valuable in advanced microscopy and spectroscopy projects.
